Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-22-012159

Options or other derivatives

  • SVP Finance; Interim CFO & PAO acquired 107,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Miller Seline E. SVP Finance; Interim CFO & PAO 2022-02-11 Grant or award · Stock Option (Right to Buy) +107,500 107,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…